
Fas Ligand-Expressing B-1a Lymphocytes Mediate CD4+-T-Cell Apoptosis during Schistosomal Infection: Induction by Interleukin 4 (IL-4) and IL-10
Author(s) -
Steven K. Lundy,
Dov L. Boros
Publication year - 2002
Publication title -
infection and immunity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 220
eISSN - 1070-6313
pISSN - 0019-9567
DOI - 10.1128/iai.70.2.812-819.2002
Subject(s) - fas ligand , biology , antigen , apoptosis , microbiology and biotechnology , cd19 , b cell , t cell , interleukin 2 , lymphocyte , immunology , immune system , antibody , programmed cell death , biochemistry
A previous study of the murine model ofSchistosoma mansoni infection has implicated splenic CD19+ B lymphocytes as Fas ligand (FasL)-bearing mediators of CD4+ T-lymphocyte apoptosis. The present study shows that B-cell deficiency leads to decreased CD4+ T-cell apoptosis during infection and compares FasL expression and killer function of B-1a- and CD5− B-lymphocyte subsets. B-1a cells from uninfected mice displayed constitutive expression of FasL compared with that of CD5− B cells. FasL expression was enhanced following worm egg deposition and antigenic stimulation on both subsets of B cells. Purified B-1a cells from uninfected mice were potent effectors of CD4+ T-cell apoptosis, and the killing effect was enhanced during schistosome infection. FasL expression by splenic B cells required CD4+ -T-cell help that was replaced by addition of culture supernatants from antigen-stimulated splenocytes of infected mice. The culture-supernatant-stimulated FasL expression was inhibited by anti-interleukin 10 (IL-10) and anti-IL-4 antibodies. Culture of purified B cells with recombinant IL-4 (rIL-4), rIL-10, and soluble egg antigens (SEA) led to increased expression of FasL on B-1a cells. These results suggest that FasL-expressing, splenic B-1a cells are important mediators of SEA-stimulated CD4+ -T-cell apoptosis and that maximal FasL expression on B-1a cells is dependent on antigenic stimulation and the presence of IL-4 and IL-10.